相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials
Nandini Dey et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Lapatinib Resistance in Breast Cancer Cells Is Accompanied by Phosphorylation-Mediated Reprogramming of Glycolysis
Benjamin Ruprecht et al.
CANCER RESEARCH (2017)
Hepatocyte growth factor/MET in cancer progression and biomarker discovery
Kunio Matsumoto et al.
CANCER SCIENCE (2017)
p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy
B. Bisaro et al.
ONCOTARGET (2016)
Tyrosine kinase receptor EGFR regulates the switch in cancer cells between cell survival and cell death induced by autophagy in hypoxia
Yongqiang Chen et al.
AUTOPHAGY (2016)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al.
AUTOPHAGY (2016)
Improved transcription and translation with L-leucine stimulation of mTORC1 in Roberts syndrome
Baoshan Xu et al.
BMC GENOMICS (2016)
The PI3K Pathway: Background and Treatment Approaches
Michael P. Lux et al.
BREAST CARE (2016)
Endocytic control of signaling at the plasma membrane
Elisa Barbieri et al.
CURRENT OPINION IN CELL BIOLOGY (2016)
Autophagic degradation of epidermal growth factor receptor in gefitinib-resistant lung cancer by celastrol
Su-Wei Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Autophagy inhibition facilitates erlotinib cytotoxicity in lung cancer cells through modulation of endoplasmic reticulum stress
Zhongliang Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway
Lin Mu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
Yu-Jen Chen et al.
ONCOTARGETS AND THERAPY (2016)
ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation
Joao Nunes et al.
ONCOTARGET (2016)
Identification of breast cancer cell subtypes sensitive to ATG4B inhibition
Svetlana Bortnik et al.
ONCOTARGET (2016)
The multifaceted role of autophagy in tumor evasion from immune surveillance
Bassam Janji et al.
ONCOTARGET (2016)
Feedback control of ErbB2 via ERK-mediated phosphorylation of a conserved threonine in the juxtamembrane domain
Yuki Kawasaki et al.
SCIENTIFIC REPORTS (2016)
Hijacker of the Antitumor Immune Response: Autophagy Is Showing Its worst Facet
Elodie Viry et al.
FRONTIERS IN ONCOLOGY (2016)
Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
Maria Luque-Cabal et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2016)
A Kinase-Independent Role for EGF Receptor in Autophagy Initiation
Xiaojun Tan et al.
CELL (2015)
Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM
Zongyuan Yang et al.
CURRENT CANCER DRUG TARGETS (2015)
Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids
Cristina E. Rodriguez et al.
PLOS ONE (2015)
Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
Mei-Chuan Tang et al.
PLOS ONE (2015)
EGFR signaling and autophagy dependence for growth, survival, and therapy resistance
Barry Jutten et al.
CELL CYCLE (2014)
Targeting of erbB3 receptor to overcome resistance in cancer treatment
Jian Ma et al.
MOLECULAR CANCER (2014)
Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790M (Publication with Expression of Concern. See vol. 14, 2019)
Kwang Sup So et al.
PLOS ONE (2014)
Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma
Yu-Jen Chen et al.
ONCOTARGET (2014)
EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance
Yongjie Wei et al.
CELL (2013)
Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma
Lei Ma et al.
FEBS JOURNAL (2013)
Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer
Junjeong Choi et al.
HISTOPATHOLOGY (2013)
Interaction between Her2 and Beclin-1 Proteins Underlies a New Mechanism of Reciprocal Regulation
Jie Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Autophagy Stimulates Apoptosis in HER2-Overexpressing Breast Cancers Treated by Lapatinib
Xingmei Zhu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer
Wieslawa H. Dragowska et al.
PLOS ONE (2013)
Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia
Yang Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival
Barry Jutten et al.
RADIOTHERAPY AND ONCOLOGY (2013)
NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells
Arya Sobhakumari et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
WWOX suppresses autophagy for inducing apoptosis in methotrexate-treated human squamous cell carcinoma
C-W Tsai et al.
CELL DEATH & DISEASE (2013)
The anti-malarial chloroquine overcomes Primary resistance and restores sensitivity to Trastuzumab in HER2-positive breast cancer
Silvia Cufi et al.
SCIENTIFIC REPORTS (2013)
EGFR tyrosine kinase inhibition induces autophagy in cancer cells
Christopher Fung et al.
CANCER BIOLOGY & THERAPY (2012)
Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models
Fulvio Chiacchiera et al.
CANCER LETTERS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer
E. P. Booy et al.
ONCOGENE (2011)
Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib
Rama Krishna Kancha et al.
PLOS ONE (2011)
The Epidermal Growth Factor Receptor Antibody Cetuximab Induces Autophagy in Cancer Cells by Downregulating HIF-1α and Bcl-2 and Activating the Beclin 1/hVps34 Complex
Xinqun Li et al.
CANCER RESEARCH (2010)
Autophagy and tumorigenesis
Nan Chen et al.
FEBS LETTERS (2010)
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
Goran Jonsson et al.
BREAST CANCER RESEARCH (2010)
Regulation of Autophagy by Reactive Oxygen Species (ROS): Implications for Cancer Progression and Treatment
Meghan B. Azad et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
HER-2 Signaling and Inhibition in Breast Cancer
B. C. Browne et al.
CURRENT CANCER DRUG TARGETS (2009)
ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery
Chang Hwa Jung et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Mitochondrially localized EGFR is subjected to autophagic regulation and implicated in cell survival
Xiaojing Yue et al.
AUTOPHAGY (2008)
Survival of cancer cells is maintained by EGFR independent of its kinase activity
Zhang Weihua et al.
CANCER CELL (2008)
The epidermal growth factor receptor family: Biology driving targeted therapeutics
M. J. Wieduwilt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Autophagy fights disease through cellular self-digestion
Noboru Mizushima et al.
NATURE (2008)
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Cai-Hong Yun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
STAT-mediated EGFR signaling in cancer
Kelly M. Quesnelle et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Association of Wwox with ErbB4 in breast cancer
Rami I. Aqeilian et al.
CANCER RESEARCH (2007)
被撤回的出版物: Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/Autophagin-3 (Retracted article. See vol. 294, pg. 1435, 2019)
Guillermo Marino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
EGFR targeting therapies: Monoclonal antibodies versus tyrosine kinase inhibitors similarities and differences
Olivier Dassonville et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: Implications for cancer therapy
Elizabeth S. Henson et al.
CELLULAR SIGNALLING (2006)
The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib
N Normanno et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Lapatinib: Current status and future directions in breast cancer
Beverly Moy et al.
ONCOLOGIST (2006)
Role of tyrosine kinase inhibitors in cancer therapy
A Arora et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy
S Pattingre et al.
CELL (2005)
Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2
KE Longva et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
HW Lo et al.
CANCER CELL (2005)
The ErbB receptors and their ligands in cancer: An overview
N Normanno et al.
CURRENT DRUG TARGETS (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
The MAPK signalling pathways and colorectal cancer
JY Fang et al.
LANCET ONCOLOGY (2005)
The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells
R Nahta et al.
CANCER RESEARCH (2004)
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
MC Franklin et al.
CANCER CELL (2004)
Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor
ZY Yue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tumor biology - Herceptin acts as an anti-angiogenic cocktail
Y Izumi et al.
NATURE (2002)
Nuclear localization of EGF receptor and its potential new role as a transcription factor
SY Lin et al.
NATURE CELL BIOLOGY (2001)
The type III epidermal growth factor receptor mutation - Biological significance and potential target for anti-cancer therapy
MW Pedersen et al.
ANNALS OF ONCOLOGY (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
